Literature DB >> 13230164

Plasma thromboplastin antecedent (PTA) deficiency; clinical, coagulation, therapeutic and hereditary aspects of a new hemophilia-like disease.

R L ROSENTHAL, O H DRESKIN, N ROSENTHAL.   

Abstract

Entities:  

Keywords:  HEMORRHAGIC DIATHESIS

Mesh:

Substances:

Year:  1955        PMID: 13230164

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  25 in total

1.  THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. I. EVIDENCE FOR THE PROPERTIES OF A NEW SERUM THROMBOPLASTIC FACTOR.

Authors:  R COLMAN; B ALEXANDER
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

2.  PROLONGED POSTOPERATIVE BLEEDING IN A PATIENT WITH FACTOR XI (PTA) DEFICIENCY.

Authors:  L L PHILLIPS; G A HYMAN; R L ROSENTHAL
Journal:  Ann Surg       Date:  1965-07       Impact factor: 12.969

3.  [Blood coagulation disorder in hyperheparinemia].

Authors:  H H SESSNER; L ROKA; E CHRISTMANN
Journal:  Klin Wochenschr       Date:  1960-10-15

4.  The action of heparin in the prevention of prothrombin conversion.

Authors:  A S DOUGLAS
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

5.  Biochemical genetics of blood coagulation.

Authors:  J B GRAHAM
Journal:  Am J Hum Genet       Date:  1956-06       Impact factor: 11.025

6.  [The so-called pseudohemophilia; follow-up of a hemophilic tribe in Saarland after 20 years].

Authors:  R KLESPER; W ACHENBACH
Journal:  Klin Wochenschr       Date:  1957-10-15

7.  [Familial deficiency of factor X].

Authors:  J OEHME; G SCHWICK; H E SCHULTZE
Journal:  Klin Wochenschr       Date:  1958-06-01

Review 8.  Some Important Milestones in the Field of Blood Clotting.

Authors:  Russell F Doolittle
Journal:  J Innate Immun       Date:  2015-12-15       Impact factor: 7.349

9.  [Blood platelets and coagulationactive plasma proteins. A short summary of their function and pathology].

Authors:  E MAMMEN; R GROSS
Journal:  Blut       Date:  1962-05

Review 10.  Factor XI and contact activation as targets for antithrombotic therapy.

Authors:  D Gailani; C E Bane; A Gruber
Journal:  J Thromb Haemost       Date:  2015-06-16       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.